Pfizer (PFE)
(Delayed Data from NYSE)
$28.86 USD
+0.41 (1.44%)
Updated Oct 28, 2024 04:00 PM ET
After-Market: $28.97 +0.11 (0.38%) 6:56 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$28.86 USD
+0.41 (1.44%)
Updated Oct 28, 2024 04:00 PM ET
After-Market: $28.97 +0.11 (0.38%) 6:56 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Zacks News
5 Bank Stocks Set to Rebound With Vaccine-Driven Economic Recovery
by Radhika Saraogi
Improving lending scenarios and restoration of normal activities in 2021, with the help of coronavirus vaccines rollout, will likely help banks like JPMorgan (JPM), Bank of Hawaii (BOH), Bank OZK (OZK), UMB Financial (UMBF) and Synovus (SNV) witness a rebound.
3 Airlines Stocks to Gain as the Economy Looks to Fully Reopen
by Zacks Equity Research
Rollout of the vaccine along with an expected fiscal stimulus is sure to boost the airlines industry, making it prudent to watch out for names like Mesa Air Group (MESA) and Spirit Airlines (SAVE).
Small-Caps at Record Highs Ahead of Christmas
by Mark Vickery
The small-cap Russell 2000 index has hit another closing record high today -- the 13th time this has occurred this year.
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Pfizer (PFE) closed the most recent trading day at $37.44, moving +1.91% from the previous trading session.
Top Stock Reports for Apple, JPMorgan & Union Pacific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), JPMorgan Chase (JPM), and Union Pacific (UNP).
5 Best-Performing Leveraged ETFs of Fourth Quarter
by Sweta Killa
We highlight some leveraged ETFs that gained more than 85% over the past three months.
Biotech Stock Roundup: PFE/BNTX Vaccine Authorized in Europe, Updates From AMGN, & More
by Zacks Equity Research
Coronavirus vaccine updates from Moderna (MRNA) and Pfizer (PFE)/BioNTech (BNTX) continue to take centerstage in the biotech sector.
BioCryst (BCRX) Provides Updates on Galidesivir, Shares Fall
by Zacks Equity Research
BioCryst (BCRX) will discontinue the study on its pipeline candidate, galidesivir, for treating patients with the novel coronavirus disease (COVID-19).
4 MedTech Stocks Up More Than 100% in 2020 With Room to Run
by Urmimala Biswas
We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.
How Effective Will Vaccines be Against New Coronavirus Strain?
by Indrajit Bandyopadhyay
Pfizer (PFE) and Moderna (MRNA), the companies whose coronavirus vaccines have been approved for emergency use, are evaluating their vaccines against the fast-spreading new strain of coronavirus found in the United Kingdom.
5 High Beta & Momentum ETFs to Tap the Santa Rally
by Sweta Killa
These ETFs are expected to outperform in the seven-day period and are intriguing choices for a short spell.
3 Large Drugmakers Set to Rule the Sector in 2021
by Kinjel Shah
Large Cap Pharmaceuticals industry players maintain a cautious outlook after mixed Q3 show. COVID-19 vaccine development efforts play a crucial role in driving the industry. PFE, MRK, NVS may prove to be good additions to your portfolio.
4 Restaurant Stocks to Play a Likely Turnaround in 2021
by Mrithunjoy Kaushik
Although the restaurant industry is grappling with the coronavirus outbreak, restaurant stocks like JACK, RUTH, FAT and STKS have impressive 2021 earnings growth projections.
Pfizer/BioNTech COVID-19 Vaccine Gets Authorization in Europe
by Zacks Equity Research
Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate is the first COVID-19 vaccine to be granted conditional authorization in Europe.
4 Airline Stocks Took Off on Vaccine Hopes: Can They Keep Flying in 2021?
by Maharathi Basu
IATA forecasts airline loss to narrow in 2021 from $118.5 billion predicted in 2020. This improved scenario should aid stocks like United Airlines (UAL), American Airlines (AAL), Spirit Airlines (SAVE) and Mesa Air (MESA).
More New Highs for Stocks With Fiscal Stimulus Looking Imminent
by David Borun
Even with rising Covid-19 cases, a deal in Washington and the vaccine rollout keep investors in a buying mood.
5 Small-Cap ETFs Set to Explode on COVID-19 Vaccines
by Sweta Killa
As the economy seems on track for strong growth, a small-cap rally is expected to strengthen in the New Year.
Christmas Week Begins With Pre-market Sell-off
by Zacks Equity Research
Christmas Week Begins With Pre-market Sell-off
Pre-Markets Down to Start Christmas Week
by Mark Vickery
Though already off the lows we saw a couple hours before today's opening bell, the Dow is down 400 points, the S&P 500 -55 and the Nasdaq -140.
Top 5 S&P 500 Stocks That Helped the Index Gain in 2020
by Aniruddha Ganguly
Here we pick five S&P 500 stocks -- NVDA, ETSY, AAPL, MSFT & AMZN -- that have helped the index deliver solid returns this year.
Moderna (MRNA) Gets FDA Emergency Use Nod for COVID-19 Vaccine
by Zacks Equity Research
Moderna (MRNA) gets emergency use authorization for coronavirus vaccine, mRNA-1273, for use in adults in the United States.
4 Restaurant Stocks to Watch as Vaccine Rollout Begins
by Zacks Equity Research
Vaccine rollout should allow dine-in to resume in restaurants with online delivery expected to sustain, making it prudent to keep an eye on names like Brinker International (EAT) and McDonald's (MCD)
Vaccines to Fuel Santa Claus Rally: 5 Stock Picks
by Sweta Killa
With only eight trading days left this year, markets are bracing for the so-called Santa Claus rally.
Moderna's (MRNA) COVID-19 Vaccine Gets FDA Panel's Backing
by Zacks Equity Research
An FDA panel recommends granting approval for emergency use to Moderna's (MRNA) coronavirus vaccine candidate.
Merck (MRK) Gets FDA's Priority Review for Another Keytruda sBLA
by Zacks Equity Research
The FDA accepts Merck's (MRK) sBLA for Keytruda combo for first-line metastatic esophageal and gastroesophageal junction cancer, under a priority review. The FDA's verdict is awaited on Apr 13, 2021.